Furthermore, hepatocellular carcinoma, the end-stage of NAFLD, displays higher POLD1 expression levels than normal liver tissues, and this is associated with a poor prognosis (57). This evidence concerns the gene POLD1 and metabolic dysfunction-associated steatotic liver disease.